Stephen Hochschuler - 26 Apr 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role: Director
Signature: /s/ Stephen H. Hochschuler
Issuer symbol: TNON
Transactions as of: 26 Apr 2022
Net transactions value: $0
Form type: 3
Filing time: 26 Apr 2022, 21:37:28 UTC
Next filing: 16 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TNON	Common Stock						19,725	26 Apr 2022	See footnote	F1
holding	TNON	Common Stock						24,900	26 Apr 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Stock Options							26 Apr 2022	Common Stock	8,536	$0.6200	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 15,253 shares of common stock issuable to SHKH, LLC, an entity for which Stephen H. Hochschuler has a controlling interest, upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022, and (ii) 4,472 shares of common stock issuable to SHKH, LLC upon the conversion of Series B Preferred Stock on the closing of the initial public offering.
F2	Stephen Hochschuler was granted an option to purchase 17,071 shares (or 8,536 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of November 15, 2016. All of the shares underlying the option have vested.

Content

Consists of (i) 15,253 shares of common stock issuable to SHKH, LLC, an entity for which Stephen H. Hochschuler has a controlling interest, upon the automatic conversion of a convertible note on the closing of the initial public offering of Tenon Medical, Inc. to occur on April 29, 2022, and (ii) 4,472 shares of common stock issuable to SHKH, LLC upon the conversion of Series B Preferred Stock on the closing of the initial public offering.

Stephen Hochschuler was granted an option to purchase 17,071 shares (or 8,536 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of November 15, 2016. All of the shares underlying the option have vested.